Maximum quantity allowed is 999
请选择数量
CAS RN: 100361-18-0 | 產品號碼: C2650
7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic Acid

* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準,敬請留意。
產品規格
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Neutralization titration) | min. 98.0 % |
Melting point | 222.0 to 226.0 °C |
NMR | confirm to structure |
性質
熔點 | 224 °C |
GHS
相關法規
運輸資料
HS編碼* | 2933.99-000 |
Application
Synthesis of 1-Cyclopropyl-1,8-naphthyridine Fluoroquinolone Antibacterials and Evaluations of their Antibacterial Activity
C2650 is an important intermediate for preparation of 1-cyclopropyl-1,8-naphthyridine fluoroquinolone antibacterials.
References
- Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids
- Quinolone antibacterial agents. Synthesis and structure-activity relationships of a series of amino acid prodrugs of racemic and chiral 7-(3-amino-1-pyrrolidinyl)quinolones. Highly soluble quinolone prodrugs with in vivo pseudomonasactivity
- Novel Fluoroquinolone Antibacterial Agents Containing Oxime-Substituted (Aminomethyl)pyrrolidines: Synthesis and Antibacterial Activity of 7-(4-(Aminomethyl)-3-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl -6-fluoro -4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic Acid (LB20304)
- Syntheses and biological evaluation of new fluoroquinolone antibacterials containing chiral oximinopyrrolidinea
- Synthesis and antibacteriala activity of novel fluoroquinolones containing substituted piperidines
- 4-Substituted 4-(1H-1,2,3-triazol-1-yl)piperidine: Novel C7 moieties of fluoroquinolones as antibacterial agents
考研文獻
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。